AGREEMENTCommercial Supply Agreement • August 10th, 2017 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • Delaware
FOURTH AMENDMENT TO LICENSE AND CO-DEVELOPMENT AGREEMENTDevelopment Agreement • August 10th, 2017 • Aptevo Therapeutics Inc. • Pharmaceutical preparations
THIS FOURTH AMENDMENT (“Fourth Amendment”) effective as of June 19, 2017 (“Effective Date”), is made by and between MorphoSys AG, a German corporation (registered at the District Court of Munich, HRB121023) having an office and place of business at Semmelweisstrasse 7, 82152Planegg, Germany, (collectively with its affiliates, “Morphosys”) and Aptevo Research and Development LLC (previously Emergent Product Development Seattle, LLC), a US corporation (registered in Delaware, N° 4858233) having an office and place of business at 2401 Fourth Avenue, Suite 1050, Seattle, Washington, USA (“Aptevo”).
